Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Topiramate 20 mg/ml Oral solution {equilateral_black_triangle}

Active Ingredient:
topiramate
Company:  
Zydus Pharmaceuticals UK Ltd See contact details
ATC code: 
N03AX11
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Letters to HCPs HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Topiramate Annual Risk Awareness Form Epilepsy (20mg/ml)

Topiramate Pregnancy Prevention Programme Annual Risk Awareness Form: Epilepsy

Topiramate should not be used in patients of childbearing potential unless the conditions of the Pregnancy Prevention Programme are fulfilled. This form outlines the condition of the topiramate Pregnancy Prevention Programme and when these must be fulfilled. This form should be used to support and record the prescribing decision

{pdf_link}

Topiramate Annual Risk Awareness Form Prophylaxis of Migraine (20mg/ml)

Topiramate Pregnancy Prevention Programme Annual Risk Awareness Form - Prophylaxis of Migraine:

Topiramate should not be used in patients of childbearing potential unless the conditions of the Pregnancy Prevention Programme are fulfilled. This form outlines the conditions of the topiramate Pregnancy Prevention Programme and when these must be fulfilled. The form should be used to support and record the prescribing decision.

{pdf_link}

Topiramate Healthcare professional guide Epilepsy (20mg/ml)

{healthcare_pro_orange} For Healthcare Professionals

Topiramate Pregnancy Prevention Programme Information on the risks of topiramate use in girls (of any age) and women of childbearing potential in the treatment of epilepsy.

{pdf_link}

Topiramate Healthcare professional guide Prophylaxis of Migraine (20mg/ml)

{healthcare_pro_orange} For Healthcare Professionals

Topiramate Pregnancy Prevention Programme Information on the risks of topiramate use in women of childbearing potential in the treatment of prophylaxis of migraine

{pdf_link}

Topiramate patient card (20mg/ml)

Important information for all female patients who could become pregnant

{pdf_link}

Topiramate Patient Guide Epilepsy (20mg/ml)

Topiramate Pregnancy Prevention Programme Patient Guide: What patients who are able to get pregnant need to know about topiramate

{pdf_link}

Topiramate Patient Guide Prophylaxis of migraine (20mg/ml)

Topiramate Pregnancy Prevention Programme Patient Guide: What patients who are able to get pregnant need to know about topiramate

{pdf_link}

Topiramate Pregnancy Warning Sticker (20mg/ml)

Sticker for Pharmacies - WARNING FOR WOMEN WHO ARE ABLE TO BECOME PREGNANT

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Zydus Pharmaceuticals UK Ltd
Company image
Address
First Floor, Templeback, 10 Temple Back, Bristol, BS1 6FL, UK
Telephone
+44 (0)1604 504 166
Medical Information Direct Line
0800 995 60 34
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)1604 504 166
WWW
www.zydusuk.com